Prolonged overall survival with lenalidomide plus dexamethasone compared with dexamethasone alone in patients with relapsed or refractory multiple myeloma

被引：13

作者：

Weber, Donna ^{[1
]}

Knight, Robert ^{[2
]}

Chen, Christine ^{[3
]}

Spencer, Andrew ^{[4
]}

Yu, Zhinuan ^{[2
]}

Zeldis, Jerome ^{[2
]}

Olesnyckyj, Marta ^{[2
]}

Dimopoulos, Meletios ^{[5
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Celgene Corp, Summit, NJ USA

[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[4] Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia

[5] Univ Athens, Sch Med, GR-11527 Athens, Greece

来源：

BLOOD | 2007年 / 110卷 / 11期

关键词：

D O I：

10.1182/blood.V110.11.412.412

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

412

引用

页码：128A / 128A

页数：1

共 50 条

[11] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone
Shin, Junghoon
Lee, Je-Jung
Kim, Kihyun
Min, Chang-Ki
Lee, Jeong-Ok
Suh, Cheolwon
Kim, Jin Seok
Lee, Yoo Jin
Yoon, Sung-Soo
Jo, Jae-Cheol
Lee, Ho Sup
Bang, Soo-Mee
Lee, Jeong-Ok
Bang, Soo-Mee
Lee, Je-Jung
Kim, Kihyun
Min, Chang-Ki
Suh, Cheolwon
Yoon, Dok Hyun
Kim, Jin Seok
Lee, Yoo Jin
Moon, Joon Ho
Yoon, Sung-Soo
Kim, Inho
Jo, Jae-Cheol
Lee, Ho Sup
Park, Seong Kyu
Shin, Ho-Jin
Kim, Min Kyoung
Mun, Yeung-Chul
Lee, Mark Hong
Park, Yong
Eom, Hyeon Seok
Kim, Hyo Jung
Im, Sung Nam
Kim, Sung-Hyun
Do, Young Rok
Lee, Won Sik
Cho, Su-Hee
Yi, Jun Ho
Lee, Jae Hoon
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 79 - 90
[12] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone
Junghoon Shin
Je-Jung Lee
Kihyun Kim
Chang-Ki Min
Jeong-Ok Lee
Cheolwon Suh
Jin Seok Kim
Yoo Jin Lee
Sung-Soo Yoon
Jae-Cheol Jo
Ho Sup Lee
Soo-Mee Bang
International Journal of Hematology, 2019, 109 : 79 - 90
[13] Erratum to: Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
Shinsuke Iida
Takaaki Chou
Shinichiro Okamoto
Hirokazu Nagai
Kiyohiko Hatake
Hirokazu Murakami
Toshiyuki Takagi
Kazuyuki Shimizu
Henry Lau
Kenichi Takeshita
Masaaki Takatoku
Tomomitsu Hotta
International Journal of Hematology, 2010, 92 (1) : 127 - 128
[14] Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX
Dimopoulos, Meletios A.
San-Miguel, Jesus
Belch, Andrew
White, Darrell
Benboubker, Lotfi
Cook, Gordon
Leiba, Merav
Morton, James
Ho, P. Joy
Kim, Kihyun
Takezako, Naoki
Moreau, Philippe
Kaufman, Jonathan L.
Sutherland, Heather J.
Lalancette, Marc
Magen, Hila
Iida, Shinsuke
Kim, Jin Seok
Prince, H. Miles
Cochrane, Tara
Oriol, Albert
Bahlis, Nizar J.
Chari, Ajai
O'Rourke, Lisa
Wu, Kaida
Schecter, Jordan M.
Casneuf, Tineke
Chiu, Christopher
Soong, David
Sasser, A. Kate
Khokhar, Nushmia Z.
Avet-Loiseau, Herve
Usmani, Saad Z.
HAEMATOLOGICA, 2018, 103 (12) : 2088 - 2096
[15] Lenalidomide plus dexamethasone demonstrates efficacy in the treatment of relapsed or refractory multiple myeloma
不详
FORMULARY, 2008, 43 (02) : 79 - 80
[16] Efficacy of lenalidomide plus dexamethasone in relapsed/refractory multiple myeloma: A systematic review
Tandy, Fenia
Hadisurya, Audrey
Suciningtias, Marlyn
Chrystelle, Celine
Kurniawan, Andree
ANNALS OF ONCOLOGY, 2022, 33 : S489 - S489
[17] Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
Chen, Christine
Reece, Donna E.
Siegel, David
Niesvizky, Ruben
Boccia, Ralph V.
Stadtmauer, Edward A.
Abonour, Rafat
Richardson, Paul
Matous, Jeffrey
Kumar, Shaji
Bahlis, Nizar J.
Alsina, Melissa
Vescio, Robert
Coutre, Steven E.
Pietronigro, Dennis
Knight, Robert D.
Zeldis, Jerome B.
Rajkumar, Vincent
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (02) : 164 - 170
[18] CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Ri, M.
Suzuki, K.
Chou, T.
Sugiura, I.
Takezako, N.
Sunami, K.
Ishida, T.
Izumi, T.
Ozaki, S.
Iida, S.
HAEMATOLOGICA, 2016, 101 : 787 - 788
[19] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
Siegel, D. S.
Richardson, P.
Dimopoulos, M.
Moreau, P.
Mitsiades, C.
Weber, D.
Houp, J.
Gause, C.
Vuocolo, S.
Eid, J.
Graef, T.
Anderson, K. C.
BLOOD CANCER JOURNAL, 2014, 4 : e182 - e182
[20] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
D S Siegel
P Richardson
M Dimopoulos
P Moreau
C Mitsiades
D Weber
J Houp
C Gause
S Vuocolo
J Eid
T Graef
K C Anderson
Blood Cancer Journal, 2014, 4 : e182 - e182

← 1 2 3 4 5 →